table of content
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Medicine Overall Market Size
2.1 Global Prostate Cancer Medicine Market Size: 2022 VS 2029
2.2 Global Prostate Cancer Medicine Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Medicine Players in Global Market
3.2 Top Global Prostate Cancer Medicine Companies Ranked by Revenue
3.3 Global Prostate Cancer Medicine Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Medicine Companies in Global Market, by Revenue in 2022
3.5 Global Companies Prostate Cancer Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Medicine Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Medicine Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Medicine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Prostate Cancer Medicine Market Size Markets, 2022 & 2029
4.1.2 LHRH Antagonists
4.1.3 LHRH Analogs
4.1.4 Antiandrogens
4.1.5 Pipeline Drugs for Hormonal Therapy
4.2 By Type - Global Prostate Cancer Medicine Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Medicine Revenue, 2018-2023
4.2.2 By Type - Global Prostate Cancer Medicine Revenue, 2024-2029
4.2.3 By Type - Global Prostate Cancer Medicine Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Medicine Market Size, 2022 & 2029
5.1.2 Age Below 55
5.1.3 Age 55-75
5.1.4 Age Above 75
5.2 By Application - Global Prostate Cancer Medicine Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Medicine Revenue, 2018-2023
5.2.2 By Application - Global Prostate Cancer Medicine Revenue, 2024-2029
5.2.3 By Application - Global Prostate Cancer Medicine Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Prostate Cancer Medicine Market Size, 2022 & 2029
6.2 By Region - Global Prostate Cancer Medicine Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Medicine Revenue, 2018-2023
6.2.2 By Region - Global Prostate Cancer Medicine Revenue, 2024-2029
6.2.3 By Region - Global Prostate Cancer Medicine Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Prostate Cancer Medicine Revenue, 2018-2029
6.3.2 US Prostate Cancer Medicine Market Size, 2018-2029
6.3.3 Canada Prostate Cancer Medicine Market Size, 2018-2029
6.3.4 Mexico Prostate Cancer Medicine Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Medicine Revenue, 2018-2029
6.4.2 Germany Prostate Cancer Medicine Market Size, 2018-2029
6.4.3 France Prostate Cancer Medicine Market Size, 2018-2029
6.4.4 U.K. Prostate Cancer Medicine Market Size, 2018-2029
6.4.5 Italy Prostate Cancer Medicine Market Size, 2018-2029
6.4.6 Russia Prostate Cancer Medicine Market Size, 2018-2029
6.4.7 Nordic Countries Prostate Cancer Medicine Market Size, 2018-2029
6.4.8 Benelux Prostate Cancer Medicine Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Medicine Revenue, 2018-2029
6.5.2 China Prostate Cancer Medicine Market Size, 2018-2029
6.5.3 Japan Prostate Cancer Medicine Market Size, 2018-2029
6.5.4 South Korea Prostate Cancer Medicine Market Size, 2018-2029
6.5.5 Southeast Asia Prostate Cancer Medicine Market Size, 2018-2029
6.5.6 India Prostate Cancer Medicine Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Prostate Cancer Medicine Revenue, 2018-2029
6.6.2 Brazil Prostate Cancer Medicine Market Size, 2018-2029
6.6.3 Argentina Prostate Cancer Medicine Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Medicine Revenue, 2018-2029
6.7.2 Turkey Prostate Cancer Medicine Market Size, 2018-2029
6.7.3 Israel Prostate Cancer Medicine Market Size, 2018-2029
6.7.4 Saudi Arabia Prostate Cancer Medicine Market Size, 2018-2029
6.7.5 UAE Prostate Cancer Medicine Market Size, 2018-2029
7 Prostate Cancer Medicine Companies Profiles
7.1 AstraZeneca plc
7.1.1 AstraZeneca plc Company Summary
7.1.2 AstraZeneca plc Business Overview
7.1.3 AstraZeneca plc Prostate Cancer Medicine Major Product Offerings
7.1.4 AstraZeneca plc Prostate Cancer Medicine Revenue in Global Market (2018-2023)
7.1.5 AstraZeneca plc Key News & Latest Developments
7.2 Active Biotech
7.2.1 Active Biotech Company Summary
7.2.2 Active Biotech Business Overview
7.2.3 Active Biotech Prostate Cancer Medicine Major Product Offerings
7.2.4 Active Biotech Prostate Cancer Medicine Revenue in Global Market (2018-2023)
7.2.5 Active Biotech Key News & Latest Developments
7.3 Bristol Myers-Squibb
7.3.1 Bristol Myers-Squibb Company Summary
7.3.2 Bristol Myers-Squibb Business Overview
7.3.3 Bristol Myers-Squibb Prostate Cancer Medicine Major Product Offerings
7.3.4 Bristol Myers-Squibb Prostate Cancer Medicine Revenue in Global Market (2018-2023)
7.3.5 Bristol Myers-Squibb Key News & Latest Developments
7.4 Teva Pharmaceuticals Industries Ltd.
7.4.1 Teva Pharmaceuticals Industries Ltd. Company Summary
7.4.2 Teva Pharmaceuticals Industries Ltd. Business Overview
7.4.3 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Major Product Offerings
7.4.4 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Revenue in Global Market (2018-2023)
7.4.5 Teva Pharmaceuticals Industries Ltd. Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Prostate Cancer Medicine Major Product Offerings
7.5.4 Johnson & Johnson Prostate Cancer Medicine Revenue in Global Market (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Pfizer Inc.
7.6.1 Pfizer Inc. Company Summary
7.6.2 Pfizer Inc. Business Overview
7.6.3 Pfizer Inc. Prostate Cancer Medicine Major Product Offerings
7.6.4 Pfizer Inc. Prostate Cancer Medicine Revenue in Global Market (2018-2023)
7.6.5 Pfizer Inc. Key News & Latest Developments
7.7 Bayer AG
7.7.1 Bayer AG Company Summary
7.7.2 Bayer AG Business Overview
7.7.3 Bayer AG Prostate Cancer Medicine Major Product Offerings
7.7.4 Bayer AG Prostate Cancer Medicine Revenue in Global Market (2018-2023)
7.7.5 Bayer AG Key News & Latest Developments
7.8 Abbott Laboratories
7.8.1 Abbott Laboratories Company Summary
7.8.2 Abbott Laboratories Business Overview
7.8.3 Abbott Laboratories Prostate Cancer Medicine Major Product Offerings
7.8.4 Abbott Laboratories Prostate Cancer Medicine Revenue in Global Market (2018-2023)
7.8.5 Abbott Laboratories Key News & Latest Developments
7.9 Astellas Pharma Inc.
7.9.1 Astellas Pharma Inc. Company Summary
7.9.2 Astellas Pharma Inc. Business Overview
7.9.3 Astellas Pharma Inc. Prostate Cancer Medicine Major Product Offerings
7.9.4 Astellas Pharma Inc. Prostate Cancer Medicine Revenue in Global Market (2018-2023)
7.9.5 Astellas Pharma Inc. Key News & Latest Developments
7.10 Roche Holding AG
7.10.1 Roche Holding AG Company Summary
7.10.2 Roche Holding AG Business Overview
7.10.3 Roche Holding AG Prostate Cancer Medicine Major Product Offerings
7.10.4 Roche Holding AG Prostate Cancer Medicine Revenue in Global Market (2018-2023)
7.10.5 Roche Holding AG Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
